📢Had a blast presenting our work on psychedelic facilitator's effects at #PS2025, catching up w/ friends, & seeing what's next for the field, like:

New trials w/ novel psychedelics?
New start-ups to help scale treatments?
Regulatory updates?
A new conference outfit for me?

So many possibilities

How much do psychedelics' subjective effects--which can predict treatment outcomes--shift depending on who guides/facilitates your experience?

Looking forward to presenting on years of trial data examining this question at #PsychedelicScience2025!

Check it out at 10am on 6/19 & hmu if in town!

‼️Excited to speak at this year's @breakingconvention.bsky.social ! I'll cover our work on how much people's subjective effects differ by who guides them, spanning years of clinical trials and hundreds of participants at @JHPsychedelics. First time attending Breaking Convention, too! 👋

How awe-inspiring are psychedelic experiences and why might emotions like awe play a role in psychedelics' benefits?
Excited to speak on this in our @affectscience.bsky.social symposium on awe today! #AffectScience2025

❓ How much do psychedelic guides influence people's hashtag psychedelic experiences in clinical trials?

📢 Next Friday at ISRP (www.isrpsych.org), I'll present some exciting work on the impacts of guides/therapists on people's psychedelic subjective effects.

6/ 🔍 Why does this matter? Accurate data from representative samples will help us understand true risk profiles and potential therapeutic benefits, ultimately shaping more effective policies & treatments.

4/ When looking at what might be driving differences between these self-reports, a variety of factors were significantly associated with positive and challenging psychedelic experiences across both studies, with dose being a common one.

3/ ⚖️ While psychedelic risks (e.g., psychological distress, need for professional help) are higher than cannabis, they are still relatively low overall. Dosing & context are critical for minimizing risks.

2/ 🌟 Psychedelics lead to more intense experiences than cannabis—both positive & negative. People report greater subjective benefits but also greater challenges and risks on psychedelics. Cannabis tends to have milder lasting impacts.